Value of serum matrix metalloproteinase-3 in the assessment of active disease in patients with rheumatoid arthritis
To investigate the value of serum matrix metalloproteinase-3 (sMMP-3) in the assessment of active disease in patients with rheumatoid arthritis (RA). One hundred and ninety-one RA patients were recruited from the Department of Rheumatology of Sun Yat-sen Memorial Hospital from June 2010 to June 2014...
Saved in:
Published in | Zhong hua yi xue za zhi Vol. 95; no. 47; p. 3823 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | Chinese |
Published |
China
15.12.2015
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | To investigate the value of serum matrix metalloproteinase-3 (sMMP-3) in the assessment of active disease in patients with rheumatoid arthritis (RA).
One hundred and ninety-one RA patients were recruited from the Department of Rheumatology of Sun Yat-sen Memorial Hospital from June 2010 to June 2014. sMMP-3 level of these RA patients and 58 healthy people was tested by enzyme-linked immunosorbent assay, while clinical data was collected simultaneously. Receiver operating characteristic (ROC) curve was used for the analysis of optimal cut-off point for the evaluation of disease activity.
There were 128 female patients and 63 male patients recruited. sMMP-3 was significantly higher in RA patients than healthy control and it was higher in patients with active disease than that in patients in remission (all P < 0.01). ROC curve analysis showed that the optimal cut-off point for diagnosing active RA was 84 μg/L with area under the curve (AUC) 0.822 in female and 168 μg/L with AUC 0.824 in male (both P < 0.01). Acc |
---|---|
ISSN: | 0376-2491 |
DOI: | 10.3760/cma.j.issn.0376-2491.2015.47.006 |